Skip to main content

IOANNIS GRIVEAS

MD,PhD

Presentations

  • 77. Cellular immunity and levels of parathyroid hormone in uremic patients receiving haemodialysis.
    I. Griveas, G. Visvardis, R. Zilidou, D. Papadopoulou E. Mitsopoulos, P. Kyriklidou, E. Manou, A. Fleva, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    XLI ERA-EDTA Congress, Lisbon Portugal, 15-18 May 2004, World Congress of Nephrology in Singapore, 26-30 June and 13th Hellenic Congress of Nephrology, 16-19 June 2004.
  • 78. Relation between risk factors of atherosclerotic disease and ultrasonography findings of carotid arteries in patients on haemodialysis.
    D. Meimaridou, G. Visvardis, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, I. Griveas E. Ginikopoulou G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    XLI ERA-EDTA Congress, Lisbon Portugal, 15-18 May 2004.
  • 79. Assessment of creatinine clearance with the method of bioimpedance.
    P. Anassis, A. Galinas, I. Griveas, A. Tzouganatou, K Andrikakou.
    Renal Unit, Sparta Hospital, Sparta Lakonia, Renal Unit, 401 Military General Hospital, Athens, Attiki, Greece.
  • 80. Inflence of dialyzers on cell subpopulations.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    3rd Hellenic Congress of Cytometry, Mykonos 13-16 May 2004.
  • 81. Acute hepatitis C in patients undergoing haemodialysis.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    13th Hellenic Nephrology Congress, Rhodos 16-19 June 2004.
  • 82. Mg levels of haemodialysis patients who receive sevelamer.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    13th Hellenic Nephrology Congress, Rhodos 16-19 June 2004.
  • 83. Influence of haemodialysis paths with high concentration on Mg on lipid profil of hemodialysis patients
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    13th Hellenic Nephrology Congress, Rhodos 16-19 June 2004.
  • 83. Infuence of long-term administration of sevelamer on lipid profil of haemodialysis patients.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    13th Hellenic Nephrology Congress, Rhodos 16-19 June 2004.
  • 84. Relationship between interleukin-6 production and plasma levels of PTH in patients on chronic hemodialysis.
    E. Tsianaka, X. Vriza, X. Xaraskou, E. Kiroglou, S. Koureli, I. Griveas, G. Visvardis, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    33rd Conference of EDTNA/ERCA, Geneva, Switzerland, 4-7 September 2004.
  • 85. Abnormalities of cellular immunity in uremic patients receiving hemodialysis.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, 417 Veterans Army Administration Hospital (NIMTS), Athens, Greece.
    22nd Annual Meeting of the International Society of Blood Purification, September 3-5, 2004, London.
  • 86. Abnormalities of cellular immunity in uremic patients receiving hemodialysis and peritoneal dialysis.
    I. Griveas, G. Visvardis, A. Fleva, D. Papadopoulou, A. Giannakou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki, Greece.
    22nd Annual Meeting of the International Society of Blood Purification, September 3-5, 2004, London and 20th Military Hellenic Congress, Thessaloniki 18-21 November 2004.
  • 87. Glomerular filtration rate estimation renal transplant patients basedon serum cystatin-C levels. Comparison with other markers of glomerular filtration rate.
    G. Visvardis, I. Griveas, R. Zilidou, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    XX International Congress of the Transplantation Society, 5-10 September 2004, Vienna, Austria and 20th Military Hellenic Congress, Thessaloniki 18-21 November 2004.
  • 88. Acute Renal Failure and Haemodialysis Methods in intensive care units
    E. Tsianaka, X. Vriza, X. Xaraskou, E. Kiroglou, S. Koureli, I. Griveas, G. Visvardis, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki.
    33rd Conference of EDTNA/ERCA, Geneva, Switzerland, 4-7 September 2004.
  • 89. QOL in patients undergoing hemodialysis vs peritoneal dialysis
    K. Gamvroula, V. Holeva, J. Griveas, G. Sakellariou, A. Karavatos.
    1st Psychiatric Clinic, Aristotle University of Thessaloniki, Nephrology Dpt, Papageorgiou General Hospital Thessaloniki.
    World Psychiatric Association Regional and International Congress ‘Advances in Psychiatry’’, 12-15 March 2005, Athens, Greece.
  • 90. Immunoadsorption in the treatment of immune-related diseases in a Nephrology Department
    G. Visvardis, E. Ginikopoulou, E. Manou, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, I. Griveas, D. Meimaridou, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki, Greece.
    5th World Congress of the International Society for Apheresis, May 3-5, 2005, Rostock, Germany.